NINGBO INNO PHARMCHEM CO.,LTD. provides Uridine 5'-Diphosphate Disodium Salt (CAS 27821-45-0), an important compound that serves as a drug discovery intermediate. In the complex process of developing new pharmaceuticals, specific molecules that interact with biological targets are crucial for identifying and optimizing potential drug candidates.

Uridine 5'-Diphosphate disodium salt is a molecule with well-defined biological activities that make it highly valuable in the early stages of drug discovery. Its capacity to act as a P2Y6 receptor agonist means it can be used to screen for compounds that enhance or modulate P2Y6 receptor activity, potentially leading to treatments for conditions where P2Y6 signaling is dysregulated. For instance, it can help identify molecules that mimic its agonist effects for therapeutic benefit.

Equally significant is its function as a GPR105 receptor inhibitor. This property allows it to be used in screening assays to find compounds that can effectively block GPR105 activity. Such inhibitors are sought after for their potential to treat inflammatory diseases and other conditions where GPR105 plays a detrimental role. Researchers looking for Uridine diphosphate for research often focus on these specific receptor interactions.

The demand to buy Uridine 5'-Diphosphate Disodium Salt stems from its utility in high-throughput screening and lead optimization processes. By providing a defined starting point for studying specific receptor families, it accelerates the identification of promising drug candidates. Working with a reliable biochemicals supplier ensures the quality and consistency necessary for these critical early-stage studies.

As a drug discovery intermediate, Uridine 5'-Diphosphate disodium salt facilitates the exploration of therapeutic strategies targeting nucleotide-binding receptors. Its involvement in pathways related to inflammation, immunity, and metabolism makes it a versatile tool for a wide range of therapeutic areas. The insights gained from studying its interactions can guide the design of more effective and safer medications.

In summary, Uridine 5'-Diphosphate Disodium Salt is a key intermediate in drug discovery, offering defined pharmacological actions as a P2Y6 receptor agonist and GPR105 receptor inhibitor. Its availability from NINGBO INNO PHARMCHEM CO.,LTD. supports the vital work of developing new medicines.